DOCSLIB.ORG

Dynamics of Normal Ovarian Follicular Development

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dynamics of Normal Ovarian Follicular Development GENE EXPRESSION PROFILING OF BOVINE OVARIAN FOLLICULAR SELECTION A Dissertation Presented to The Faculty of the Graduate School University of Missouri-Columbia In Partial Fulfillment Of the Requirement for the Degree Doctor of Philosophy By Zhilin Liu Dr. Eric Antoniou, Dissertation Supervisor December 2006 The undersigned, appointed by the Dean of the Graduate School, have examined the dissertation entitled Gene expression profiling of Bovine Ovarian Follicular Selection Presented by Zhilin Liu a candidate for the degree of Doctor of Philosophy and hereby certify that in their opinion it is worthy of acceptance. _______________________________________ Dr. Eric Antoniou _______________________________________ Dr. H. Allen Garverick _______________________________________ Dr. Gary S. Johnson _______________________________________ Dr. William R. Lamberson _______________________________________ Dr. Michael Smith _______________________________________ Dr. Jerry Taylor ACKNOWLEDGEMENTS First I would like to take this opportunity to express my appreciation to my advisor, Dr. Eric Antoniou, for letting me pursue my doctoral degree under his guidance. For more than six years, he has provided an encouraging environment for me to learn and grow in the research. His consistent guidance and cordial advice on my research have been invaluable. Many thanks to my committee members: Dr. Allen H. Garverick, Dr. William R. Lamberson, Dr. Gary S. Johnson, Dr. Michael Smith and Dr. Jerry Taylor for their encouragement and mentoring throughout my course of studies and completion of this work. Very special thanks to Dr. H. Allen Garverick and his lab member Malinda N. Burkhart, Dr. Robert S. Youngquist, Dr. Jerry Taylor and his lab member Erin M. Sellner, for their direct collaborations on different parts of this dissertation research. Without their generous help, this project would not be completed as smoothly as today. I would also like to thank Dr. Leonard B. Hearne for his expertise on microarray analysis and Dr. Dennis B. Lubahn for his concern and help. Many thanks to my current lab members, Sachin Bhusari, Mallikarjuna S. Basavarajappa, Jaewoo Kim as well as previous lab member, Jarrod J. Robertson for their help with science and lab work, and for creating an enjoyable lab together. I also need to extend my thanks to those who have been there along the way, including Raja S. Settivari, Dr. Kristi M. Cammack, Dr. Tim Safranski, Dr. Robert Schnabel, Jinghua Liu, Yi ii Zhuang and many other people in ASRC. Special thanks to Ms. Cynthia L. Glascock and Ms. Doris A. Lyons for their enormous assistance. Last, and certainly not least, appreciation is expressed to my loving and supporting family. I would like to express my deepest thanks to my parents and my sisters for their constant love and support throughout my life. Finally, and most importantly, none of this could have been completed without the love and support of my wife Wei Zhou. Thanks for all your help on science, for all the understanding and encouragement, for taking care of me and providing a warm home. You are the ones who make me a better person. Thanks. iii TABLE OF CONTENTS ACKNOWLEDGEMENTS........................................................................................... ii TABLE OF CONTENTS.............................................................................................. iv LIST OF TABLES.......................................................................................................viii LIST OF FIGURES....................................................................................................... ix LIST OF ABBREVIATION ......................................................................................... xi ABSTRACT .................................................................................................................xiii Chapter I ......................................................................................................................... 1 Introduction .................................................................................................................... 1 Chapter II........................................................................................................................ 4 Literature review............................................................................................................ 4 Introduction.................................................................................................................. 4 Follicular development ................................................................................................ 5 Preantral and antral follicle dynamics..................................................................... 5 Deviation and size advantage.................................................................................. 7 Gonadotropin regulation of follicular recruitment and selection............................ 8 Mechanisms of follicle selection ............................................................................... 12 FSH: follicle-coupling hypothesis ........................................................................ 12 LH and LH receptors ............................................................................................ 14 Estradiol ................................................................................................................ 15 Key steroidogenic enzymes .................................................................................. 18 TGFß superfamily members ................................................................................. 19 iv IGF-system............................................................................................................ 22 Role of macrophages............................................................................................. 27 Apoptosis .............................................................................................................. 29 Summary.................................................................................................................... 34 Chapter III .................................................................................................................... 36 Construction of a Bovine cDNA Array....................................................................... 36 Abstract...................................................................................................................... 36 Introduction................................................................................................................ 36 Results........................................................................................................................ 38 A. Construction of the array.................................................................................. 39 B. Sample labeling and hybridization................................................................... 45 Summary.................................................................................................................... 49 Chapter IV .................................................................................................................... 50 Data Storage and Bioinformatics Analysis................................................................. 50 Abstract...................................................................................................................... 50 Introduction................................................................................................................ 50 Results........................................................................................................................ 51 A. BASE for data storage and normalization........................................................ 51 B. MAANOVA for statistical analysis ................................................................. 52 C. TMEV for clustering ........................................................................................ 53 D. DAVID for gene list functional annotation...................................................... 53 E. Gene annotation................................................................................................ 54 Chapter V...................................................................................................................... 60 Molecular Mechanisms Regulating of Bovine Ovarian Follicular Selection .......... 60 Abstract...................................................................................................................... 60 v Introduction................................................................................................................ 61 Materials and methods............................................................................................... 63 Animals and treatments......................................................................................... 63 Tissue processing.................................................................................................. 64 Hormone analysis.................................................................................................. 64 RNA Extraction .................................................................................................... 65 Microarray preparation ......................................................................................... 65 Microarray hybridization .....................................................................................
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Role of Peroxisomes in Granulosa Cells, Follicular Development and Steroidogenesis
    Role of peroxisomes in granulosa cells, follicular development and steroidogenesis in the mouse ovary Inaugural Dissertation submitted to the Faculty of Medicine in partial fulfillment of the requirements for the PhD-Degree of the Faculties of Veterinary Medicine and Medicine of the Justus Liebig University Giessen by Wang, Shan of ChengDu, China Gießen (2017) From the Institute for Anatomy and Cell Biology, Division of Medical Cell Biology Director/Chairperson: Prof. Dr. Eveline Baumgart-Vogt Faculty of Medicine of Justus Liebig University Giessen First Supervisor: Prof. Dr. Eveline Baumgart-Vogt Second Supervisor: Prof. Dr. Christiane Herden Declaration “I declare that I have completed this dissertation single-handedly without the unauthorized help of a second party and only with the assistance acknowledged therein. I have appropriately acknowledged and referenced all text passages that are derived literally from or are based on the content of published or unpublished work of others, and all information that relates to verbal communications. I have abided by the principles of good scientific conduct laid down in the charter of the Justus Liebig University of Giessen in carrying out the investigations described in the dissertation.” Shan, Wang November 27th 2017 Giessen,Germany Table of Contents 1 Introduction ...................................................................................................................... 3 1.1 Peroxisomal morphology, biogenesis, and metabolic function ...................................... 3 1.1.1
    [Show full text]
  • Neurosteroid Metabolism in the Human Brain
    European Journal of Endocrinology (2001) 145 669±679 ISSN 0804-4643 REVIEW Neurosteroid metabolism in the human brain Birgit Stoffel-Wagner Department of Clinical Biochemistry, University of Bonn, 53127 Bonn, Germany (Correspondence should be addressed to Birgit Stoffel-Wagner, Institut fuÈr Klinische Biochemie, Universitaet Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany; Email: [email protected]) Abstract This review summarizes the current knowledge of the biosynthesis of neurosteroids in the human brain, the enzymes mediating these reactions, their localization and the putative effects of neurosteroids. Molecular biological and biochemical studies have now ®rmly established the presence of the steroidogenic enzymes cytochrome P450 cholesterol side-chain cleavage (P450SCC), aromatase, 5a-reductase, 3a-hydroxysteroid dehydrogenase and 17b-hydroxysteroid dehydrogenase in human brain. The functions attributed to speci®c neurosteroids include modulation of g-aminobutyric acid A (GABAA), N-methyl-d-aspartate (NMDA), nicotinic, muscarinic, serotonin (5-HT3), kainate, glycine and sigma receptors, neuroprotection and induction of neurite outgrowth, dendritic spines and synaptogenesis. The ®rst clinical investigations in humans produced evidence for an involvement of neuroactive steroids in conditions such as fatigue during pregnancy, premenstrual syndrome, post partum depression, catamenial epilepsy, depressive disorders and dementia disorders. Better knowledge of the biochemical pathways of neurosteroidogenesis and
    [Show full text]
  • Disruption of Androgen Metabolism, Regulation and Effects: Involvement of Steroidogenic Enzymes
    Disruption of Androgen Metabolism, Regulation and Effects: Involvement of Steroidogenic Enzymes Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Cornelia Fürstenberger, aus Basel, Schweiz Basel, 2014 Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Alex Odermatt (Fakultätsverantwortlicher) ________________________ Fakultätsverantwortlicher Prof. Dr. Alex Odermatt und Prof. Dr. Rik Eggen (Korreferent) ________________________ Korreferent Prof. Dr. Rik Eggen Basel, den 20. Mai 2014 ________________________ Dekan Prof. Dr. Jörg Schibler 2 Table of content Table of content I. Abbreviations ................................................................................................................................. 6 1. Summary ........................................................................................................................................ 9 2. Introduction .................................................................................................................................. 12 2.1 Steroid hormones .................................................................................................................. 12 2.2 Steroidogenesis ..................................................................................................................... 14 2.3 Steroid hormones in health and disease ..............................................................................
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models
    cancers Article Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models Subrata Deb 1 , Steven Pham 2, Dong-Sheng Ming 2, Mei Yieng Chin 2, Hans Adomat 2, Antonio Hurtado-Coll 2, Martin E. Gleave 2,3 and Emma S. Tomlinson Guns 2,3,* 1 Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL 33169, USA; [email protected] 2 The Vancouver Prostate Centre at Vancouver General Hospital, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada; [email protected] (S.P.); [email protected] (D.-S.M.); [email protected] (M.Y.C.); [email protected] (H.A.); [email protected] (A.H.-C.); [email protected] (M.E.G.) 3 Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada * Correspondence: [email protected]; Tel.: +1-604-875-4818 Received: 14 August 2018; Accepted: 17 September 2018; Published: 20 September 2018 Abstract: Castration-resistant prostate tumors acquire the independent capacity to generate androgens by upregulating steroidogenic enzymes or using steroid precursors produced by the adrenal glands for continued growth and sustainability. The formation of steroids was measured by liquid chromatography-mass spectrometry in LNCaP and 22Rv1 prostate cancer cells, and in human prostate tissues, following incubation with steroid precursors (22-OH-cholesterol, pregnenolone, 17-OH-pregnenolone, progesterone, 17-OH-progesterone). Pregnenolone, progesterone, 17-OH-pregnenolone, and 17-OH-progesterone increased C21 steroid (5-pregnan-3,20-dione, 5-pregnan-3,17-diol-20-one, 5-pregnan-3-ol-20-one) formation in the backdoor pathway, and demonstrated a trend of stimulating dihydroepiandrosterone or its precursors in the backdoor pathway in LNCaP and 22Rv1 cells.
    [Show full text]
  • Expression of Selected Genes Involved in Steroidogenesis in the Course of Enucleation-Induced Rat Adrenal Regeneration
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 33: 613-623, 2014 Expression of selected genes involved in steroidogenesis in the course of enucleation-induced rat adrenal regeneration MARIANNA TYCZEWSKA, MARCIN RUCINSKI, AGNIESZKA ZIOLKOWSKA, MARCIN TREJTER, MARTA SZYSZKA and LUDWIK K. MALENDOWICZ Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland Received October 28, 2013; Accepted December 6, 2013 DOI: 10.3892/ijmm.2013.1599 Abstract. The enucleation-induced (EI) rapid proliferation however, throughout the entire experimental period, there were of adrenocortical cells is followed by their differentiation, no statistically significant differences observed. After the initial the degree of which may be characterized by the expression decrease in steroidogenic factor 1 (Sf-1) mRNA levels observed of genes directly and indirectly involved in steroid hormone on the 1st day of the experiment, a marked upregulation in its biosynthesis. In this study, out of 30,000 transcripts of genes expression was observed from there on. Data from the current identified by means of Affymetrix Rat Gene 1.1 ST Array, we study strongly suggest the role of Fabp6, Lipe and Soat1 in aimed to select genes (either up- or downregulated) involved supplying substrates of regenerating adrenocortical cells for in steroidogenesis in the course of enucleation-induced adrenal steroid synthesis. Our results indicate that during the first days regeneration. On day 1, we found 32 genes with altered of adrenal regeneration, intense synthesis of cholesterol may expression levels, 15 were upregulated and 17 were down- occur, which is then followed by its conversion into cholesteryl regulated [i.e., 3β-hydroxysteroid dehydrogenase (Hsd3β), esters.
    [Show full text]
  • An Essential Component in Steroid Synthesis, the Steroidogenic Acute Regulatory Protein, Is Expressed in Discrete Regions of the Brain
    The Journal of Neuroscience, December 15, 2002, 22(24):10613–10620 An Essential Component in Steroid Synthesis, the Steroidogenic Acute Regulatory Protein, Is Expressed in Discrete Regions of the Brain Steven R. King,1,2,3 Pulak R. Manna,4 Tomohiro Ishii,6 Peter J. Syapin,5 Stephen D. Ginsberg,7 Kevin Wilson,4 Lance P. Walsh,4 Keith L. Parker,6 Douglas M. Stocco,4 Roy G. Smith,2,3 and Dolores J. Lamb1,3 1Scott Department of Urology, 2Huffington Center on Aging, and 3Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, Departments of 4Cell Biology and Biochemistry and 5Pharmacology, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, 6Departments of Internal Medicine and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and 7Center for Dementia Research, Nathan Kline Institute, New York University School of Medicine, Orangeburg, New York 10962 Recent data implicate locally produced steroids, termed neuro- sistent with a role in de novo neurosteroidogenesis, StAR co- steroids, as regulators of neuronal function. Adrenal and go- localizes with the cholesterol side-chain cleavage enzyme nadal steroidogenesis is controlled by changes in the steroido- P450scc in both mouse and human brains. These data support genic acute regulatory protein (StAR); however, little is known a role for StAR in the production of neurosteroids and identify about the regulation of neurosteroid production. We now dem- potential sites of active de novo steroid synthesis in the brain. onstrate unequivocally that StAR mRNA and protein are ex- Key words: neurosteroid; steroidogenic acute regulatory pro- pressed within glia and neurons in discrete regions of the tein; P450scc ; steroidogenesis; cholesterol side-chain cleavage mouse brain, and that glial StAR expression is inducible.
    [Show full text]
  • The Hedgehog Signaling Pathway in the Mouse Ovary
    THE HEDGEHOG SIGNALING PATHWAY IN THE MOUSE OVARY A Dissertation Presented to the Faculty of the Graduate School of Cornell University in Fulfillment of the Requirement for the Degree of Doctor of Philosophy by Yi Ren January 2012 © 2012 Yi Ren THE HEDGEHOG SIGNALING PATHWAY IN THE MOUSE OVARY Yi Ren, Ph. D. Cornell University 2012 The hedgehog (HH) signaling pathway plays critical roles in the Drosophila ovary. Previous studies have provided basic information on the pattern of expression of genes within the HH signaling pathway in the mouse ovary and on potential effects of HH signaling on cultured ovarian cells. An in vivo approach with transgenic mice is necessary to determine the function of HH signaling. The studies in this dissertation used the Amhr2cre/+SmoM2 transgenic mouse line to investigate phenotypes associated with over-activation of hedgehog signaling in the ovary. Results of these studies determined that HH signaling can influence ovarian follicle development. Female Amhr2cre/+SmoM2 mice are infertile. Although mutant mice had developmental defects in the Mullerian duct, the primary cause of infertility was the failure of ovulation based on the fact that oocytes were trapped in the follicles of superovulated mice. No difference in HH signaling activity was detected between controls and mutants around the time of ovulation. Cumulus expansion was suboptimal but could not explain the complete loss of fertility in the mutants. Luteinization occurred and generated normal levels of progesterone in plasma, although there was a delay in corpus luteum (CL) formation. The major phenotype in the ovaries of mutant mice was reduced mRNA levels of genes typical of smooth muscle in the thecal-interstitial compartment and reduced expression of smooth muscle actin (SMA) associated with blood vessels in the theca, indicating that the thecal vasculature failed to mature.
    [Show full text]
  • C:\Myfiles\Linda's Work\Houchens\WA 2-6
    1 2 This page intentionally left blank. 3 4 Draft Steroidogenesis DRP 110 May 2002 1 6.0 DEVELOPMENTAL STATUS OF THE ASSAY AND RECOMMENDATIONS 2 FOR PREVALIDATION STUDIES 3 4 6.1 Current Status 5 6 The endpoint included in the sectioned testes assay has been evaluated in other studies. 7 However, the protocol itself has not been validated. Pending a final decision on the study 8 design, the protocol would be ready to enter the prevalidation phase. 9 10 6.2 Recommendation for Optimization of the Sectioned Testis Assay Protocol 11 12 6.2.1 Testicular Preparation Issues 13 14 Optimization of the assay could be determined for the amount of testis actually needed to 15 obtain a given level of sensitivity. For example, a single testis from an adult SD rat weighs 16 approximately 1 g. If such a testis were quarter sectioned, then each section would weigh 17 approximately 250 mg, which is the weight of the sample generally described by investigators 18 who have used quartered sections of testis. However, no documentation was found that 19 demonstrates whether smaller sections would give similar results. Thus, it would be 20 advantageous to conduct a study that investigates whether the sensitivity of the preparation is 21 affected by the amount of testicular tissue used and, if so, if there is an optimal and/or threshold 22 amount to use. The weight of the sections to be tested could range from the customary amount 23 used, i.e., 250 mg, down to an amount of tissue that represents a practical minimum, e.g., 5 to 24 10 mg.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • 3.1 Multiple Mechanisms Mediate Glia-Induced Synaptogenesis in Rgcs
    III. RESULTS III. R ESULTS 3.1 Multiple mechanisms mediate glia-induced synaptogenesis in RGCs Starting from the publication of Nägler et al. (2001), which showed that soluble glial- derived factors enhance the formation and efficacy of synapses in cultured RGCs, and of Mauch et al. (2001), which identified cholesterol as one of this glia derived factors, I studied how cholesterol and other secreted factors from glial cells influence synapse development in microcultures of highly purified rat RGCs. To separate effects mediated by GCM and by cholesterol, which is contained in GCM in form of lipoproteins (LaDu et al., 1998; DeMattos et al., 2001), I treated microcultures of RGCs in parallel with GCM or with cholesterol at the same concentration (5 µg/ml) as in GCM (Mauch et al., 2001). 3.1.1 Time course of GCM- and cholesterol-induced changes in the number of synapses As a first step, measurements in the lab (D Mauch & FW Pfrieger) showed how fast GCM and cholesterol enhance the level of synaptic activity in RGCs, by measuring spontaneous, asynchronous and evoked EPSCs. As shown in Fig. 4, cholesterol and GCM raised the frequencies of spontaneous and asynchronous release and the size of miniature and evoked EPSCs to the same extent and with a similarly slow time course, leading to significant changes after three or more days of treatment. This raised the question whether cholesterol- and GCM enhanced the number of synapses with the same time course. To resolve this question, I added GCM or cholesterol to five day old microcultures of RGCs and examined after different periods of treatment the number of synapses in neurons growing singly or in small groups on microislands of PDL.
    [Show full text]